News

MiCAN Establishes German Subsidiary for MylcMAT Deployment

Notice of Fundraising through Third-Party Allotment of New Shares

Our CEO Miyazaki will present MylcMAT at Pharmalab2024 held in Dusseldorf.

We will hold a seminar on dengue fever at NIHE.

We will be presenting a poster at the “PDA Pharmaceutical Microbiology Conference 2024.”

Now exhibiting at BioJapan, Asia’s largest partnering event (Venue: PACIFICO Yokohama) Dates: 2024.10.9 (Wed) – 2022.10.11 (Fri)。

Fushihara will be speaking at “Global Growth Unlocked: Overseas Strategies of Drug Discovery Startups”.

We have concluded a joint research and development agreement with Miura Co., Ltd.

We will have a booth at the 51st Annual Meeting of the Japanese Society of Toxicology.

We will participate in the BIO International Convention 2024.

We will exhibit at the 23rd Congress of the Japanese Society for Regenerative Medicine.

We will be conducting a panel discussion on alternative methods to animal experimentation at the Hyper Interdisciplinary Conference 2024 TOKYO.